Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-25-003762
Filing Date
2025-04-08
Accepted
2025-04-08 16:36:08
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27721
2 filename2.txt TEXT-EXTRACT 1194
  Complete submission text file 0000000000-25-003762.txt   40216
Mailing Address 217 W. MAIN STREET SOMERVILLE NJ 08876
Business Address 217 W. MAIN STREET SOMERVILLE NJ 08876 908-370-5102
ZyVersa Therapeutics, Inc. (Filed for) CIK: 0001859007 (see all company filings)

EIN.: 862685744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD | File No.: 333-286396
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)